title: Novel vitamin d analogs for prostate cancer therapy.
abstract: Prostate cells contain specific receptors for 1α,25-dihydroxyvitamin D [1α,25(OH)(2)D] or calcitriol, the active form of vitamin D. 1α,25(OH)(2)D is known to inhibit the proliferation and invasiveness of prostate cancer cells. These findings support the use of 1α,25(OH)(2)D for prostate cancer therapy. However, 1α,25(OH)(2)D can cause hypercalcemia, analogs of 1α,25(OH)(2)D that are less calcemic but exhibit potent antiproliferative activity would be attractive as therapeutic agents. To accomplish these goals, different strategies, based on metabolism, molecular mechanism of actions, and structural modeling, have been taken to modify the structure of vitamin D molecule with the aims to improve the efficacy and decrease the toxicity of vitamin D to treat different diseases. During the past four decades, over 3,000 analogs have been synthesized. In this paper, we discuss the development and the biological analysis of a unique class of vitamin D analogs with a substitution at the carbon 2 of 19-nor-1α,25(OH)(2)D(3) molecule for potential application to the prevention and treatment of prostate cancer as well as other cancers.
authors.affiliation: Boston University School of Medicine, Room M-1022, 715 Albany Street, Boston, MA 02118, USA.
authors.forename: Tai C
authors.initials: TC
authors.lastname: Chen
authors.forename: Atsushi
authors.initials: A
authors.lastname: Kittaka
references.citation: Clin Cancer Res. 2000 Mar;6(3):901-8
references.pmid: 10741714
references.citation: Proc Natl Acad Sci U S A. 1981 Aug;78(8):4990-4
references.pmid: 6946446
references.citation: J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):689-93
references.pmid: 17241782
references.citation: Anticancer Res. 2006 Jul-Aug;26(4A):2621-31
references.pmid: 16886672
references.citation: Org Lett. 2001 Nov 29;3(24):3975-7
references.pmid: 11720583
references.citation: Proc Natl Acad Sci U S A. 1994 May 10;91(10):4293-7
references.pmid: 8183903
references.citation: Blood. 1998 Oct 1;92(7):2441-9
references.pmid: 9746784
references.citation: Med World. 1946 Aug 9;64(26):807-10
references.pmid: 20282870
references.citation: J Org Chem. 2003 Sep 19;68(19):7407-15
references.pmid: 12968893
references.citation: J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):269-76
references.pmid: 17223554
references.citation: Carcinogenesis. 2006 Jan;27(1):32-42
references.pmid: 15987715
references.citation: J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):717-20
references.pmid: 17207993
references.citation: FASEB J. 2000 Jul;14(10):1455-63
references.pmid: 10877839
references.citation: Blood. 1989 Jul;74(1):82-93
references.pmid: 2665845
references.citation: J Org Chem. 2004 Oct 29;69(22):7463-71
references.pmid: 15497970
references.citation: Trends Endocrinol Metab. 2003 Nov;14(9):423-30
references.pmid: 14580762
references.citation: Biochim Biophys Acta. 2011 Jan;1814(1):186-99
references.pmid: 20619365
references.citation: Chem Biol. 1999 May;6(5):265-75
references.pmid: 10322128
references.citation: Annu Rev Biochem. 1976;45:631-66
references.pmid: 183601
references.citation: Am J Kidney Dis. 1995 Nov;26(5):852-60
references.pmid: 7485144
references.citation: J Med Chem. 2006 May 18;49(10):2909-20
references.pmid: 16686534
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: Curr Top Med Chem. 2006;6(12):1273-88
references.pmid: 16848741
references.citation: Bioconjug Chem. 2007 May-Jun;18(3):614-20
references.pmid: 17408240
references.citation: Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S48-54
references.pmid: 9808143
references.citation: Drug Metab Dispos. 2005 Jun;33(6):778-84
references.pmid: 15764712
references.citation: J Natl Cancer Inst. 1997 Feb 5;89(3):212-8
references.pmid: 9017001
references.citation: Recent Results Cancer Res. 2003;164:273-88
references.pmid: 12899529
references.citation: Anticancer Res. 2006 Jul-Aug;26(4A):2567-72
references.pmid: 16886665
references.citation: Endocrinology. 2007 Oct;148(10):4887-94
references.pmid: 17628009
references.citation: Cesk Dermatol. 1949;24(4):145-9
references.pmid: 18152072
references.citation: J Urol. 1998 Jun;159(6):2035-9; discussion 2039-40
references.pmid: 9598513
references.citation: J Med Chem. 2002 Aug 1;45(16):3366-80
references.pmid: 12139448
references.citation: J Med Chem. 2006 Nov 30;49(24):7063-75
references.pmid: 17125259
references.citation: Anticancer Res. 2009 Sep;29(9):3547-53
references.pmid: 19667147
references.citation: Mol Aspects Med. 2008 Dec;29(6):433-52
references.pmid: 18554710
references.citation: J Biol Chem. 1994 Apr 8;269(14):10545-50
references.pmid: 8144641
references.citation: Biochemistry. 1983 Jul 19;22(15):3636-40
references.pmid: 6311251
references.citation: Clin Cancer Res. 2003 Sep 15;9(11):4077-83
references.pmid: 14519629
references.citation: J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):151-6
references.pmid: 18938245
references.citation: Clin Cancer Res. 2002 Sep;8(9):2820-7
references.pmid: 12231522
references.citation: Urol Oncol. 1995 Sep-Oct;1(5):195-8
references.pmid: 21224117
references.citation: Mol Cancer Ther. 2009 Jul;8(7):1787-98
references.pmid: 19584236
references.citation: Br J Clin Pract. 1996 Mar;50(2):88-93
references.pmid: 8731645
references.citation: J Med Chem. 2006 Aug 24;49(17):5199-205
references.pmid: 16913708
references.citation: Cancer Metastasis Rev. 1998-1999;17(4):353-60
references.pmid: 10453279
references.citation: Lancet. 1947 Sep 13;2(6472):398
references.pmid: 20263553
references.citation: Biochem Pharmacol. 1992 Dec 15;44(12):2273-80
references.pmid: 1472092
references.citation: Science. 1979 Dec 7;206(4423):1188-90
references.pmid: 505004
references.citation: Curr Top Med Chem. 2006;6(12):1289-96
references.pmid: 16848742
references.citation: Bioorg Med Chem. 2008 Jul 15;16(14):6949-64
references.pmid: 18539034
references.citation: Biol Pharm Bull. 2006 Nov;29(11):2246-50
references.pmid: 17077522
references.citation: J Biol Chem. 2002 May 10;277(19):E8
references.pmid: 11991957
references.citation: Eur Urol. 2011 Aug;60(2):279-90
references.pmid: 21592649
references.citation: FEBS Lett. 1987 Dec 21;226(1):58-62
references.pmid: 2826255
references.citation: Endocrinology. 1980 Dec;107(6):1916-22
references.pmid: 6253281